Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-Covid”

225 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 225 results

Early research (Phase 1)Study completedNCT04409925
What this trial is testing

DISmantling COvid iNduced Neutrophil ExtraCellular Traps (DISCONNECT-1)

Who this might be right for
COVID-19 Infection
McGill University Health Centre/Research Institute of the McGill University Health Centre 15
Not applicableUnknownNCT04634214
What this trial is testing

The Severity of COVID 19 in Diabetes and Non-diabetes Patients

Who this might be right for
Covid19Type2 Diabetes
India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals 1,050
Not applicableStudy completedNCT06191393
What this trial is testing

SARS-CoV-2 and Influenza A/B in Point-of-Care and Non-Laboratory Settings

Who this might be right for
SARS-CoV-2 InfectionInfluenza AInfluenza B
Aptitude Medical Systems 614
Not applicableTemporarily pausedNCT04359836
What this trial is testing

Explore the Role of Gut Flora in COVID-19 Infection

Who this might be right for
Gut MicrobiomeGastrointestinal MicrobiomeCOVID+7 more
ProgenaBiome 250
Testing effectiveness (Phase 2)Study completedNCT04527081
What this trial is testing

Study of COVID-19 DNA Vaccine (AG0302-COVID19)

Who this might be right for
COVID-19
AnGes, Inc. 30
Large-scale testing (Phase 3)UnknownNCT04935476
What this trial is testing

Dapsone Coronavirus SARS-CoV-2 Trial (DAP-CORONA) COVID-19

Who this might be right for
COVID-19
McGill University Health Centre/Research Institute of the McGill University Health Centre 3,000
Testing effectiveness (Phase 2)Study completedNCT04421404
What this trial is testing

Effects of COVID-19 Convalescent Plasma (CCP) on Coronavirus-associated Complications in Hospitalized Patients

Who this might be right for
COVID-19Sars-CoV2
Priscilla Hsue, MD 34
Not applicableUnknownNCT04834947
What this trial is testing

Hemodynamic Effect of Prone Position in Non-intubated Patient With COVID 19

Who this might be right for
Covid19Pneumonia, Viral
Hospices Civils de Lyon 30
Testing effectiveness (Phase 2)Study completedNCT05765773
What this trial is testing

An Open Comparative Study of the Effectiveness and Incomparable Study of the Immunogenicity and Safety of the Vaccine (CoviVac) for Adults Aged 60 Years and Older

Who this might be right for
Corona Virus InfectionVaccineCOVID-19
Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products 200
Post-approval studies (Phase 4)Study completedNCT05305651
What this trial is testing

Study to Monitor the Occurrence of Viral Variants in Patients With Compromised Immune Systems Being Treated for COVID-19

Who this might be right for
COVID-19
GlaxoSmithKline 217
Post-approval studies (Phase 4)Ended earlyNCT05057897
What this trial is testing

AZD1222, a Vaccine for the Prevention of COVID-19 in Immunocompromised Adults

Who this might be right for
COVID-19, SARS-CoV-2
AstraZeneca 34
Not applicableStudy completedNCT05289141
What this trial is testing

Interest in the Use of Nasal High-Flow Oxygen Therapy (OptiFlow™) in Secondary Transport of COVID-19 Positive Patients

Who this might be right for
COVID-19
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer 229
Not applicableUnknownNCT05753202
What this trial is testing

TDCS in Post-COVID Syndrome: Comparison of Two Targets

Who this might be right for
COVID-19Post-COVID-19 SyndromePost COVID-19 Condition
Hospital San Carlos, Madrid 40
Testing effectiveness (Phase 2)Looking for participantsNCT07157007
What this trial is testing

Early-stage Trial to Determine a Safe and Effective Dose for Ratutrelvir in Patients With Mild to Moderate COVID-19

Who this might be right for
COVID - 19
Traws Pharma, Inc. 90
Testing effectiveness (Phase 2)Active Not RecruitingNCT06597396
What this trial is testing

Study to Investigate the Efficacy of Abrocitinib in Adult Participants With Severe Fatigue From Post COVID Condition/Long COVID

Who this might be right for
Post-COVID ConditionFatigue Symptom
Beth Israel Deaconess Medical Center 46
Not applicableStudy completedNCT04402879
What this trial is testing

CORONA (COvid pRONe hypoxemiA): Prone Positioning for Hypoxemic COVID-19 Patients With Do-not-intubate Goals

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2COVID-19Acute Respiratory Distress Syndrome+2 more
University of Calgary 596
Not applicableStudy completedNCT05894590
What this trial is testing

Post-Marketing Non-Acute Safety Study in Japan After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA-1273 COVID-19 Vaccine in Persons at High Risk of Severe COVID-19

Who this might be right for
SARS-CoV-2
ModernaTX, Inc. 13,680
Testing effectiveness (Phase 2)Study completedNCT04492891
What this trial is testing

Cyclosporine For The Treatment Of COVID-19(+)

Who this might be right for
SARS (Disease)
Bryan Burt, MD 47
Post-approval studies (Phase 4)Study completedNCT04619680
What this trial is testing

The Study of the Use of Nintedanib in Slowing Lung Disease in Patients With Fibrotic or Non-Fibrotic Interstitial Lung Disease Related to COVID-19

Who this might be right for
Pulmonary FibrosisInterstitial Lung DiseaseRespiratory Disease
Icahn School of Medicine at Mount Sinai 103
Not applicableStudy completedNCT04365959
What this trial is testing

The Prone Position in Covid-19 Affected Patients

Who this might be right for
Sars-CoV2
University of Milano Bicocca 56
Next Page